MRC1 and neoplasm: These findings indicate that while baseline demographic factors (age, sex, RAS status, tumour location) were largely comparable, significant imbalances were observed in ECOG performance status, metastatic distribution, MMR testing, prior chemotherapy intensity, and the use of biological agents.